Top Markets
#1 Black Phoenix Black Phoenix +355.39%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.09%
#4 Akedo Akedo +46.58%
#5 Acurast Acurast +34.72%
#6 BasedHype BasedHype +25.74%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.14%
#8 Avantis Avantis +22.16%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Hisse Senetlerindeki Sıralama #40889
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Hisse Fiyatı
$0.0127
Son senkronizasyon: 2026-08-12
Piyasa Değeri
$66.48K
Değişim (1 gün)
-2.31%
Değişim (1 yıl)
-67.44%
Ülke
US
Ticaret Vincerx Pharma, Inc. (VINC)

Kategori

Healthcare
Vincerx Pharma, Inc. (VINC) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.01 - 2026-08-01

Gün sonu en düşük fiyat: $195.93 - 2020-05-01
Vincerx Pharma, Inc. için hisse fiyatı geçmişi: 2020 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $522.59 31.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.65 33.57%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE